SCHEMBL11049862

SCHEMBL11049862

COc1ccc(Oc2cccc(OC)c2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.77
LTA4H P09960 2/20 0.70
MTNR1B P49286 8/20 0.61
MTNR1A P48039 6/20 0.61
ALDH1A1 P00352 2/20 0.58
MEN1 O00255 1/20 0.58
MITF O75030 1/20 0.58
GAA P10253 1/20 0.58
MAPT P10636 1/20 0.58
GFER P55789 1/20 0.58
KMT2A Q03164 1/20 0.58
NLRP1 Q9C000 1/20 0.58
NOD2 Q9HC29 1/20 0.58
PGR P06401 3/20 0.56
KDM4E B2RXH2 2/20 0.54
HTT P42858 1/20 0.54
ACHE P22303 1/20 0.54
RELA Q04206 1/20 0.53
POLB P06746 1/20 0.53
CA12 O43570 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4608736 0.98 SMN1; SMN2 (0.73) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL10709191 0.98 SMN1; SMN2 (0.80) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL15834450 0.93 LTA4H (0.82) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL13167638 0.93 SMN1; SMN2 (0.72) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL1061713 0.93 SMN1; SMN2 (0.72) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL30053231 0.93 SMN1; SMN2 (0.72) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL29929943 0.93 SMN1; SMN2 (0.72) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL491308 0.91 SMN1; SMN2 (0.70) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL30358269 0.89 SMN1; SMN2 (0.69) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1
SCHEMBL3484768 0.89 SMN1; SMN2 (0.69) SMN1; SMN2LTA4HMTNR1BMTNR1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12017972-B2 All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2024-06-25 US disclosed
US-12017972-B2 All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2024-06-25 US disclosed
US-20220153956-A1 Polyimide-Gold-Nanorod J-aggregates with Broadened Surface Plasmonic Resonance Band and Method of Manufacture GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2022-05-19 US disclosed
WO-2011118845-A1 POLYESTER RESIN, AND OPTICAL MATERIALS, FILMS AND IMAGE DISPLAY DEVICES USING THE SAME FUJIFILM CORPORATION (JP) 2011-09-29 WO disclosed
US-7541466-B2 Tetrahydroisoquinoline derivatives for treating protein trafficking diseases GENZYME CORPORATION (US) 2009-06-02 US disclosed
US-7368068-B2 Sulfonic group-containing polyarylene block copolymer, process for production thereof, solid polymer electrolyte and proton conductive membrane JSR CORPORATION (JP) 2008-05-06 US disclosed
EP-0026991-B1 AROMATIC POLYESTER AND FILAMENTS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-03-21 EP disclosed
US-4269965-A COMPRISING MONOMERS OF P-HYDROXYBENZOIC ACID, 3,4'-DIHYDROXYBENZOPHENONE OR TEREPHTHALOYLDI(3-METHYL-4-HYDROXYBENZENE, AND TEREPHTHALIC ACID; LUSTER E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-05-26 US disclosed
EP-0026991-A1 Aromatic polyester and filaments E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-04-15 EP disclosed
US-4042603-A SUBSTITUTED DIBENZOFURAN OR 9-FLUORENONE FROM A DIPHENYL ETHER OR BENZOPHENONE UBE INDUSTRIES, LTD. (JA) 1977-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12017972-B2 All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom TPR, AS3MT, ASF1A SMN1; SMN2 3987/4885LTA4H 2586/4885MTNR1B 4859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.